U-Blot® Research Grade PatritumabCat. No. WA3340Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade PatritumabCat. No. WA3340U-Blot® Research Grade PateclizumabCat. No. WA3339Request quote
Size: 50ug/100ug
U-Blot® Research Grade PatecibartCat. No. WA3338Request quote
Size: 50ug/100ug
U-Blot® Research Grade pasritamigCat. No. WA3337Request quote
Size: 50ug/100ug
U-Blot® Research Grade PasotuxizumabCat. No. WA3336Request quote
Size: 50ug/100ug
U-Blot® Research Grade PascolizumabCat. No. WA3335Request quote
Size: 50ug/100ug
U-Blot® Research Grade ParsatuzumabCat. No. WA3334Request quote
Size: 50ug/100ug
U-Blot® Research Grade ParidiprubartCat. No. WA3333Request quote
Size: 50ug/100ug
U-Blot® Research Grade PanobacumabCat. No. WA3332Request quote
Size: 50ug/100ug
U-Blot® Research Grade PankomabCat. No. WA3331Request quote
Size: 50ug/100ug
U-Blot® Research Grade PanitumumabCat. No. WA3330Request quote
Size: 50ug/100ug
U-Blot® Research Grade PamvatamigCat. No. WA3329Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
X+(1)-866-986-9598